Company intelligence / Profile preview

Hebei Lingding Biotechnology

Ownership: Private
Development stage: Preclinical

Overview

Hebei Lingding Biotechnology is a Chinese company established in 2021 that specializes in the research, production, and sales of pharmaceutical raw materials, pharmaceutical intermediates, cosmetic raw materials, veterinary medicines, plant extracts, and organic chemicals. The company offers more than 1,000 products but does not appear to have a proprietary clinical pipeline or published clinical results.

Modalities: Small moleculePeptidesProtein
Industry: Chemicals & Materials

Drug pipeline

3 assets

tirzepatide

Pre-clinical

Indications: Weight loss

2 more assets in the full pipeline.

Request access →

Partnerships

Not specified; likely operates as an independent supplier/distributor.

Beyond the preview

Go deeper on Hebei Lingding Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Lingding Biotechnology.

Explore the full profile